Novonesis A/S (LON: 0Q4U)

Market Cap	21.68B
Revenue (ttm)	2.58B
Net Income (ttm)	239.76M
Shares Out	n/a
EPS (ttm)	0.86
PE Ratio	90.42
Forward PE	n/a
Dividend	0.46 (0.11%)
Ex-Dividend Date	Aug 30, 2024

Volume	12,240
Average Volume	167,984
Open	406.80
Previous Close	406.98
Day's Range	406.80 - 415.10
52-Week Range	38.30 - 60.79
Beta	0.54
RSI	50.19
Earnings Date	Feb 26, 2025

About Novonesis

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotto...

• Industry: Miscellaneous Chemical Products
• Founded: 1925
• Employees: 6,756
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q4U

Financial Performance

In 2023, Novonesis's revenue was 17.90 billion, an increase of 1.97% compared to the previous year's 17.55 billion. Earnings were 3.02 billion, a decrease of -17.74%.

Financial numbers in EUR